Corbion CEO Olivier Rigaud steps down: Corbion stock sits 6.74 percent below its high

Published on 10/05/2026 at 16:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half sales fell 2.20 percent to EUR 631.10 million. Corbion stock costs EUR 21.58 on October 5, 2026 versus EUR 21.70.

Bunte Comic-Illustration eines Wissenschaftlers im Labormantel an einem Bioreaktor — Pop-Art-Comic-Szene mit Wissenschaftler am Bioreaktor illustriert die Innovationskraft von Corbion N.V. (ISIN NL0010583399), Illustration mit AI erstellt.

Corbion stock was trading at EUR 21.58 at Lang & Schwarz on October 5, 2026 at 3:59 p.m. CEST, 6.74 percent below its 52-week high of EUR 23.14. On October 2, 2026, Corbion announced that CEO Olivier Rigaud will not seek a third term and will leave when his current appointment expires at the Annual General Meeting on May 12, 2027.

Leadership change sets a 2027 milestone

Rigaud has led Corbion for eight years, and the supervisory board has started a succession process. The same announcement proposes Alexander Wessels for appointment to the supervisory board at an extraordinary general meeting, adding a second governance change to the transition plan.

The timing matters because Corbion is executing its BRIGHT 2030 strategy while working to improve profitability. The leadership handover is scheduled for May 12, 2027, giving the company a defined date for continuity planning rather than an immediate executive vacancy.

First-half sales grew organically

In the first half of 2026, Corbion reported sales of EUR 631.10 million, down 2.20 percent from EUR 645.60 million in the first half of 2025, according to Yahoo Finance. Organic sales nevertheless increased 2.10 percent, with volume and mix contributing 4.00 percent while pricing reduced growth by 1.90 percent.

Adjusted EBITDA, a measure of operating earnings before interest, taxes, depreciation and amortization, fell to EUR 88.80 million from EUR 106.60 million, a 16.70 percent reported decline. Operating profit also decreased to EUR 42.10 million from EUR 63.50 million, showing that the sales improvement in underlying volumes has not yet translated into comparable earnings.

Margin guidance remains the key test

Management maintained its full-year 2026 organic sales growth outlook of 3.00 percent to 6.00 percent and free cash flow guidance of EUR 85.00 million to EUR 90.00 million. It refined the adjusted EBITDA margin outlook to above 16.00 percent from a previous indication of 17.00 percent, with higher costs and pricing effects shaping the second-half comparison.

For investors, the central tension is visible in the numbers: organic demand improved, but reported sales, adjusted EBITDA and operating profit all declined in the first half. Corbion therefore enters the leadership transition with a clear operational task, converting volume growth and expected second-half cash generation into stronger earnings.

Stock remains below its yearly high

Corbion stock was trading at EUR 21.58 at Lang & Schwarz on October 5, 2026 at 3:59 p.m. CEST. That was minus 0.55 percent versus the Lang & Schwarz prior close of EUR 21.70 on October 2, 2026, while the 52-week range stood at EUR 16.37 to EUR 23.14.

Market capitalization was EUR 1.2 billion as of October 5, 2026. The further course of trading is shown by the continuously updated real-time quote of Corbion stock.